Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

Clinical trial NCT05431933 · COMPLETED

Trial details

NCT number: NCT05431933
Sponsor: LG Chem
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Poliomyelitis Vaccine Reaction

Start date: 2023-01-10
Primary completion: 2024-11-06
Enrollment: 2001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.